BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27634917)

  • 1. In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    Argudín MA; Dodémont M; Taguemount M; Roisin S; de Mendonça R; Deplano A; Nonhoff C; Denis O
    J Antimicrob Chemother; 2017 Jan; 72(1):56-59. PubMed ID: 27634917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of clinical isolates of oxacillin-susceptible mecA-positive Staphylococcus aureus in China from 2009 to 2014.
    Song Y; Cui L; Lv Y; Li Y; Xue F
    J Glob Antimicrob Resist; 2017 Dec; 11():1-3. PubMed ID: 28729204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
    Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
    Zhang H; Xiao M; Kong F; O'Sullivan MV; Mao LL; Zhao HR; Zhao Y; Wang H; Xu YC
    Int J Antimicrob Agents; 2015 Apr; 45(4):347-50. PubMed ID: 25649348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
    Vandendriessche S; Kadlec K; Schwarz S; Denis O
    J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
    Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
    Cantón R; Livermore DM; Morosini MI; Díaz-Regañón J; Rossolini GM;
    J Antimicrob Chemother; 2017 Feb; 72(2):431-436. PubMed ID: 27798220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
    Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
    J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
    Antonelli A; Giani T; Coppi M; Di Pilato V; Arena F; Colavecchio OL; Conte V; Santerre Henriksen A; Rossolini GM;
    J Antimicrob Chemother; 2019 Dec; 74(12):3453-3461. PubMed ID: 31652323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].
    Kırca Yılmaz S; Acuner IC; Strommenger B; Bek Y; Witte W
    Mikrobiyol Bul; 2014 Jan; 48(1):14-27. PubMed ID: 24506712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Antimicrob Chemother; 2015 Jul; 70(7):2053-6. PubMed ID: 25814163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity among methicillin-resistant Staphylococcus aureus isolates carrying the mecC gene in Belgium.
    Deplano A; Vandendriessche S; Nonhoff C; Denis O
    J Antimicrob Chemother; 2014 Jun; 69(6):1457-60. PubMed ID: 24526516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4')-Ia and the efflux pump genes msrA/msrB.
    Pérez-Vázquez M; Vindel A; Marcos C; Oteo J; Cuevas O; Trincado P; Bautista V; Grundmann H; Campos J;
    J Antimicrob Chemother; 2009 Jan; 63(1):21-31. PubMed ID: 18948410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
    Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
    J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
    Alm RA; McLaughlin RE; Kos VN; Sader HS; Iaconis JP; Lahiri SD
    J Antimicrob Chemother; 2014 Aug; 69(8):2065-75. PubMed ID: 24777906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil.
    Andrade-Figueiredo M; Leal-Balbino TC
    BMC Microbiol; 2016 Jun; 16(1):115. PubMed ID: 27325108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and molecular typing of Staphylococcus aureus bloodstream isolates from hospitals in Peru.
    García C; Rijnders MI; Bruggeman C; Samalvides F; Stobberingh EE; Jacobs J
    J Infect; 2012 Nov; 65(5):406-11. PubMed ID: 22750236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals.
    Housman ST; Sutherland CA; Nicolau DP
    Int J Antimicrob Agents; 2014 Sep; 44(3):235-41. PubMed ID: 25052866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.